Co-Diagnostics, Inc. to Host Booth at Medical Fair Brasil 2022 in São Paulo on May 3-6

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq: CODX) announced its participation at the Medical Fair Brasil from May 3-6, 2022, in São Paulo. This international exhibition focuses on hospital and diagnostic supplies, attracting key healthcare professionals. Co-Dx will showcase its innovative molecular diagnostic technologies, including a new point-of-care rapid PCR diagnostics platform. The event offers an opportunity for Company representatives to connect directly with decision-makers in healthcare, enhancing product visibility and potential sales.

SALT LAKE CITY, May 3, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the Medical Fair Brasil, held May 3-6, 2022, at the Expo Center Norte in São Paulo, Brazil.

The international exhibition on hospital, diagnostic, pharmaceutical, medical and rehabilitation equipment and supplies is described on its website as a communication channel with the healthcare sector where companies present their products, innovations and services with the purpose of supplying and transforming the healthcare chain. With visitors including hospital and laboratory managers and administrators, laboratory technicians, clinicians, and physicians, Co-Dx believes that the fair will provide opportunities for Company representatives and distributors to introduce Company products directly to those individuals responsible for making purchasing decisions for their institutions.  

Attendees interested in learning more about the Company and its products, including its upcoming point-of-care and at-home rapid PCR diagnostics platform, are invited to visit Booth # 204.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booth-at-medical-fair-brasil-2022-in-sao-paulo-on-may-3-6-301538513.html

SOURCE Co-Diagnostics

FAQ

What event is Co-Diagnostics attending in May 2022?

Co-Diagnostics, Inc. is attending the Medical Fair Brasil from May 3-6, 2022.

Where is the Medical Fair Brasil being held?

The Medical Fair Brasil is being held at the Expo Center Norte in São Paulo, Brazil.

What products will Co-Diagnostics showcase at the Medical Fair Brasil?

Co-Diagnostics will showcase its molecular diagnostic technologies, including a point-of-care rapid PCR diagnostics platform.

What is the significance of the Medical Fair Brasil for Co-Diagnostics?

The fair provides Co-Diagnostics an opportunity to present products directly to healthcare professionals who make purchasing decisions.

What is the booth number for Co-Diagnostics at the Medical Fair Brasil?

Co-Diagnostics will be located at Booth #204 at the Medical Fair Brasil.